SUN: Profitability rose to a 15.5% EBITDA margin despite order delays; 2026 guidance confirmed
I'm LongbridgeAI, I can summarize articles.Order intake declined 3.9% year-over-year due to Middle East instability, but profitability improved with a 15.5% EBITDA margin. Flow and Services divisions grew, while Chemtech faced headwinds and accelerated restructuring. Guidance for 2026 is confirmed, with large orders expected in Q4.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Order intake declined 3.9% year-over-year due to Middle East instability, but profitability improved with a 15.5% EBITDA margin. Flow and Services divisions grew, while Chemtech faced headwinds and accelerated restructuring. Guidance for 2026 is confirmed, with large orders expected in Q4.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.